These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33906125)

  • 1. Animal models for SARS-CoV-2.
    Lee CY; Lowen AC
    Curr Opin Virol; 2021 Jun; 48():73-81. PubMed ID: 33906125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell and animal models of SARS-CoV-2 pathogenesis and immunity.
    Leist SR; Schäfer A; Martinez DR
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32887790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models for COVID-19.
    Muñoz-Fontela C; Dowling WE; Funnell SGP; Gsell PS; Riveros-Balta AX; Albrecht RA; Andersen H; Baric RS; Carroll MW; Cavaleri M; Qin C; Crozier I; Dallmeier K; de Waal L; de Wit E; Delang L; Dohm E; Duprex WP; Falzarano D; Finch CL; Frieman MB; Graham BS; Gralinski LE; Guilfoyle K; Haagmans BL; Hamilton GA; Hartman AL; Herfst S; Kaptein SJF; Klimstra WB; Knezevic I; Krause PR; Kuhn JH; Le Grand R; Lewis MG; Liu WC; Maisonnasse P; McElroy AK; Munster V; Oreshkova N; Rasmussen AL; Rocha-Pereira J; Rockx B; Rodríguez E; Rogers TF; Salguero FJ; Schotsaert M; Stittelaar KJ; Thibaut HJ; Tseng CT; Vergara-Alert J; Beer M; Brasel T; Chan JFW; García-Sastre A; Neyts J; Perlman S; Reed DS; Richt JA; Roy CJ; Segalés J; Vasan SS; Henao-Restrepo AM; Barouch DH
    Nature; 2020 Oct; 586(7830):509-515. PubMed ID: 32967005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models for studying coronavirus infections and developing antiviral agents and vaccines.
    Lin Q; Lu C; Hong Y; Li R; Chen J; Chen W; Chen J
    Antiviral Res; 2022 Jul; 203():105345. PubMed ID: 35605699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
    Kaptein SJF; Jacobs S; Langendries L; Seldeslachts L; Ter Horst S; Liesenborghs L; Hens B; Vergote V; Heylen E; Barthelemy K; Maas E; De Keyzer C; Bervoets L; Rymenants J; Van Buyten T; Zhang X; Abdelnabi R; Pang J; Williams R; Thibaut HJ; Dallmeier K; Boudewijns R; Wouters J; Augustijns P; Verougstraete N; Cawthorne C; Breuer J; Solas C; Weynand B; Annaert P; Spriet I; Vande Velde G; Neyts J; Rocha-Pereira J; Delang L
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26955-26965. PubMed ID: 33037151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications.
    Yuan L; Tang Q; Zhu H; Guan Y; Cheng T; Xia N
    Emerg Microbes Infect; 2021 Dec; 10(1):1881-1889. PubMed ID: 34490832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
    Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
    J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
    Lieber CM; Kang H-J; Sobolik EB; Sticher ZM; Ngo VL; Gewirtz AT; Kolykhalov AA; Natchus MG; Greninger AL; Suthar MS; Plemper RK
    J Virol; 2024 Sep; 98(9):e0090524. PubMed ID: 39207133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of selected animal models for respiratory coronavirus infection and its application in drug research.
    Qin S; Li R; Zheng Z; Zeng X; Wang Y; Wang X
    J Med Virol; 2022 Jul; 94(7):3032-3042. PubMed ID: 35285034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
    Conforti A; Marra E; Palombo F; Roscilli G; Ravà M; Fumagalli V; Muzi A; Maffei M; Luberto L; Lione L; Salvatori E; Compagnone M; Pinto E; Pavoni E; Bucci F; Vitagliano G; Stoppoloni D; Pacello ML; Cappelletti M; Ferrara FF; D'Acunto E; Chiarini V; Arriga R; Nyska A; Di Lucia P; Marotta D; Bono E; Giustini L; Sala E; Perucchini C; Paterson J; Ryan KA; Challis AR; Matusali G; Colavita F; Caselli G; Criscuolo E; Clementi N; Mancini N; Groß R; Seidel A; Wettstein L; Münch J; Donnici L; Conti M; De Francesco R; Kuka M; Ciliberto G; Castilletti C; Capobianchi MR; Ippolito G; Guidotti LG; Rovati L; Iannacone M; Aurisicchio L
    Mol Ther; 2022 Jan; 30(1):311-326. PubMed ID: 34547465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferrets: A powerful model of SARS-CoV-2.
    Zhao Y; Wang CL; Gao ZY; Qiao HX; Wang WJ; Liu XY; Chuai X
    Zool Res; 2023 Mar; 44(2):323-330. PubMed ID: 36799224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.